Lecture 6 - Natural history and differential diagnosis of bipolar disorder Flashcards
Regarding bipolar and its clinical characteristics:
a) When does it typically start
b) Estimate lifetime prevalence
c) In a year how many patients will have a severe mood episode
a) Often < 25 years
b) Varies around 1% for BD I & BD II
c) Bipolar II - 68% will have a severe mood episode, Bipolar I - 74.5% will have a severe episode
In Bipolar disorder are patients typically euthymic, manic or depressed?
Most common is for patients to have periods of euthymia and depression > mania
True for BD I & II
Some distinguishing features may be BD II patients tend to have more mood episodes and more depressed episodes than BD I
Name some features identified in the BRIDGE study identifying characteristics of Bipolar in those with current depression?
Equal or more than two prior mood episodes Symptoms beginning before aged 30 Substance abuse Borderline personality disorder Psychotic features Mixed states FHx of hypomania/mania Previous manic/hypomanic switch or mood lability on antidepressants
Which areas activated in emotional pain are similar to those activated in physical pain?
PAG (periaqueductal gray)
Accumbens
Thalamus
How many patients with bipolar II have a co-morbid personality disorder diagnosis?
1 in 3 - EUPD (BPD) is most common
Data from Vieta 1999
In the study by Juruena, Young, Clare how did BPD and Bipolar differentiate with regards to psychoneuroendocrine measures?
BPD:
- Those with high CTQ for physical abuse -decreasing cortisol
- As cortisol decreased BHS (hopelessness) increased
- Those with high CTQ for sexual abuse - increase cortisol
- In Bipolar high CTQ for sexual abuse - lower cortisol levels
How did Cleare and Markopoulou distinguish treatment resistant bipolar and treatment resistance depression with regards to cortisol levels?
Bipolar disorder was shown to have have lower cortisol levels than healthy controls and TRD
Name some features of the natural history of bipolar disorder
Early onset Lifelong recurrence risk High rates of incomplete remission Low rates of sustained recovery Suicide risk Frequent mixed symptomatology
Define some challenges treating Bipolar disorder
- Under-diagnosed / detected
- Depression can present first impacting above
- Co-morbidity common and can affect detection and treatment
- Treating both manic, depressive and mixed states
- Several subtypes requiring individualised treatment plans
Describe different treatment stages of bipolar disorder
- Acute treatment - from symptoms to remission (maybe 6-12 weeks)
- Continuation treatment - from point where symptoms first improve to where remission expected if left untreated. Deals with tail of vulnerability at first remission where recurrence risk may be high. Includes possible post-mania depression
- Maintenance treatment - Prevents or attenuates future mood episodes
Describe/define the following terms - if possible with scoring systems and/or time frames:
- Response
- Remission
- Recovery
- Relapse
- Recurrence
Response - 50% or more in reduction of core symptoms
Remission:
• mania: YMRD < 8 or < 5
• depression: HMDS < 7 or BDRS ≤8
Recovery - 8 weeks without mania/depressed symptoms
Relapse - return of symptoms within 8 weeks - may be to same or opposite pole
Recurrence - new episode - will occur > 8 weeks after remission
Which are the goals of Cognitive behavioural therapy for bipolar disorder?
1) Medication adherence
2) Early detection/intervention
3) Stress and lifestyle management
4) Treat co-morbidities
5) Treat Bipolar disorder
First symptoms to appear in a manic episode:
- More suspicious (paranoid)
- Anxious/worried (fear)
- Irritable, grumpy, angry
- Racing thoughts (feeling that you can’t control the way you think)
First symptoms to appear in depression:
Less: • Sleep • Energy or motivation • Socialising • Level of activity • Concentration / remembering
Also changes in appetite
What is the impact of BD in cognition?
Oscillation between episodes could impact brain areas such as the hippocampus and amygdala. Thus, there is a progressive decrease in cognition in these patients.